Question

1. Initial public offerings (IPOs) were covered in the chapter. Let’s take a closer look at the two actual issues. Go to www.hoovers.com/global/ipoc/index.xhtml. (of the website does not work please use any website to complete the task) For the first two issues under “Latest Pricings,” do the following steps all the way through, one company at a time. Use the menu in the top left margin to navigate the IPO.

a.) Click on and write down the company name.

b.) Write a short paragraph about what the company des or its problem.

c.) Scroll down and record the date the company went public.

d.) Write down the actual offer price

e.) Write down the offerings amount (mil)

f.) Record the name of the lead underwriter.

Answer 1

a) Company Name:

1- Aridis Pharmaceuticals

2- Mesa Air Group

b) 1- Aridis Pharmaceuticals: late-stage biopharmaceutical company focused on the discovery and

development of targeted immunotherapy using fully human monoclonal antibodies,or mAbs, to treat life-threatening infections. mAbs represent an innovative treatment approach that harnesses the human immune system to fight.

2) Mesa Air Group- Mesa Airlines is a regional air carrier providing scheduled passenger service to 110 cities in 38 states, the District of Columbia, Canada, Mexico, Cuba and the Bahamas. All of our flights are operated as either American Eagle or United Express flights pursuant to the terms of capacity purchase

c) Offer Date:

Aridis Pharmaceuticals: 8/14/2018

Mesa Air Group: 8/10/2018

d) Offer Price:

Aridis Pharmaceuticals: $13.00

Mesa Air Group: $12.00

e) Offering Amount:

Aridis Pharmaceuticals: $26,000,000.00

Mesa Air Group:$115,560,000.00

f) Lead Underwriter:

Aridis Pharmaceuticals: $13.00

Mesa Air Group: $12.00

e) Offering Amount:

Aridis Pharmaceuticals: Cantor Fitzgerald Maxim Group LLC

Mesa Air Group:Raymond James and BofA Merrill Lynch